Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 10 Results

Title
Intervention Indication Therapeutic Area Year Actions
Basal Insulin-Fc for type 2 diabetes mellitus Basal Insulin-Fc Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Canagliflozin for type 2 diabetes mellitus in children and adolescents Canagliflozin (Invokana; canagliflozin hemihydrate) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Dulaglutide for Type 2 diabetes Dulaglutide (LY2189265; Trulicity) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Empagliflozin with linagliptin for treating type 2 diabetes mellitus in children and adolescents Empagliflozin (Jardiance; DINAMO) , Linagliptin Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
IcoSema for treating adults with type 2 diabetes IcoSema (NN1535) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2023 View  |  Download
Insulin icodec for treating Type 1 and Type 2 diabetes Insulin icodec Type 1 diabetes , Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Oral Semaglutide for the treatment of type 2 diabetes mellitus Semaglutide (Ozempic) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2018 View  |  Download
Semaglutide for treating peripheral arterial disease (PAD) and type 2 diabetes Semaglutide (Ozempic) Peripheral arterial disease (PAD) , Type 2 diabetes Cardiovascular System , Endocrine Nutritional and Metabolic Disorders 2022 View  |  Download
Sotagliflozin for type 2 diabetes mellitus Sotagliflozin (Zynquista; SAR439954; LX4211) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2019 View  |  Download
Tirzepatide for treating type 2 diabetes mellitus Tirzepatide (LY3298176) Type 2 diabetes Endocrine Nutritional and Metabolic Disorders 2021 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications